Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
/in Colorectal Cancer, Hyperthermia, International PublicationsDendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies
/in Dendritic Cells, International Publications, Thyroid CancerDendritic cell-based immunotherapy for the treatment of hematological malignancies
/in Acute Leukemia, Dendritic Cells, International Publications, Multiple Myeloma[Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B]
/in Chronic Virus Hepatitis, International PublicationsTRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
/in International Publications, Ovarian Cancer[Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin]
/in Gallbladder Cancer, International PublicationsApplication of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract
/in Colorectal Cancer, International PublicationsIn vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cells
/in International Publications, Pancreatic CancerIfosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma, NSCLC
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer